BR112014017587A2 - Methods and Formulations for the Treatment of Sialic Acid Deficiencies - Google Patents

Methods and Formulations for the Treatment of Sialic Acid Deficiencies

Info

Publication number
BR112014017587A2
BR112014017587A2 BR112014017587A BR112014017587A BR112014017587A2 BR 112014017587 A2 BR112014017587 A2 BR 112014017587A2 BR 112014017587 A BR112014017587 A BR 112014017587A BR 112014017587 A BR112014017587 A BR 112014017587A BR 112014017587 A2 BR112014017587 A2 BR 112014017587A2
Authority
BR
Brazil
Prior art keywords
methods
sialic acid
formulations
treatment
acid deficiencies
Prior art date
Application number
BR112014017587A
Other languages
Portuguese (pt)
Other versions
BR112014017587A8 (en
Inventor
D Kakkis Emil
Original Assignee
Ultragenyx Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ultragenyx Pharmaceutical Inc filed Critical Ultragenyx Pharmaceutical Inc
Publication of BR112014017587A2 publication Critical patent/BR112014017587A2/en
Publication of BR112014017587A8 publication Critical patent/BR112014017587A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Abstract

resumo métodos e formulações para o tratamento de deficiências de ácido siálico a presente invenção está relacionada às composições e aos métodos para tratamento de deficiências de ácido siálico que compreendem formulações de liberação estendida.Summary Methods and Formulations for the Treatment of Sialic Acid Deficiencies The present invention relates to compositions and methods for treating sialic acid deficiencies comprising extended release formulations.

BR112014017587A 2012-01-18 2013-01-18 Methods and Formulations for the Treatment of Sialic Acid Deficiencies BR112014017587A8 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261588069P 2012-01-18 2012-01-18
US201261709549P 2012-10-04 2012-10-04
PCT/US2013/022167 WO2013109906A2 (en) 2012-01-18 2013-01-18 Methods and formulations for treating sialic acid deficiencies

Publications (2)

Publication Number Publication Date
BR112014017587A2 true BR112014017587A2 (en) 2017-06-13
BR112014017587A8 BR112014017587A8 (en) 2017-07-04

Family

ID=48799814

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014017587A BR112014017587A8 (en) 2012-01-18 2013-01-18 Methods and Formulations for the Treatment of Sialic Acid Deficiencies

Country Status (9)

Country Link
EP (1) EP2804600A4 (en)
JP (2) JP2015504094A (en)
KR (1) KR20150000872A (en)
CN (1) CN104271125A (en)
AU (1) AU2013209610B2 (en)
BR (1) BR112014017587A8 (en)
CA (1) CA2862836A1 (en)
IL (1) IL233225A0 (en)
WO (1) WO2013109906A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9241896B2 (en) 2008-12-19 2016-01-26 Ultragenyx Pharmaceutical Inc. Methods and formulations for treating sialic acid deficiencies
EP2593109A4 (en) 2010-07-13 2014-01-08 Ultragenyx Pharmaceutical Inc Method and formulations for treating sialic acid deficiencies
CA2849114C (en) 2011-10-24 2020-12-15 Ultragenyx Pharmaceutical Inc. Sialic acid analogs
TW201720803A (en) 2015-09-14 2017-06-16 超基因克斯製藥公司 Crystal forms of sialic acid or salt or solvate thereof
EP3486326A1 (en) 2017-11-21 2019-05-22 Jennewein Biotechnologie GmbH Method for the purification of n-acetylneuraminic acid from a fermentation broth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010529021A (en) * 2007-05-31 2010-08-26 アメリカ合衆国 N-acetylmannosamine as a therapeutic agent
US20100159001A1 (en) * 2008-12-19 2010-06-24 Cardinal John R Extended-Release Pharmaceutical Formulations
WO2010131712A1 (en) * 2009-05-15 2010-11-18 財団法人ヒューマンサイエンス振興財団 Therapeutic pharmaceutical agent for diseases associated with decrease in function of gne protein, food composition, and food additive
EP2593109A4 (en) * 2010-07-13 2014-01-08 Ultragenyx Pharmaceutical Inc Method and formulations for treating sialic acid deficiencies
CA2849114C (en) * 2011-10-24 2020-12-15 Ultragenyx Pharmaceutical Inc. Sialic acid analogs

Also Published As

Publication number Publication date
AU2013209610B2 (en) 2017-11-30
CA2862836A1 (en) 2013-07-25
IL233225A0 (en) 2014-08-31
EP2804600A2 (en) 2014-11-26
AU2013209610A1 (en) 2014-07-10
KR20150000872A (en) 2015-01-05
EP2804600A4 (en) 2015-09-02
JP2015504094A (en) 2015-02-05
JP2017186381A (en) 2017-10-12
CN104271125A (en) 2015-01-07
WO2013109906A2 (en) 2013-07-25
BR112014017587A8 (en) 2017-07-04

Similar Documents

Publication Publication Date Title
BR112013000776A2 (en) Method and Formulation for Treatment of Sialic Acid Deficiency
DOP2014000233A (en) MICROARN COMPOUNDS AND MIR-21 ACTIVITY MODULATION METHODS
UY35787A (en) USEFUL COMPOSITIONS TO TREAT KIT-RELATED DISORDERS
BR112016012862A2 (en) neoplasia vaccine formulations
BR112015021999A2 (en) 2,3-dioxigenase indoleamine inhibitors (acid)
CR20130480A (en) NEW IMMUNOCATE PLAYERS
CR20120413A (en) DERIVATIVES OF FUMARATE OF FATTY ACID AND ITS USES
CL2013001947A1 (en) Pharmaceutical composition comprising pioglitazone; use of pioglitazone to treat Alzheimer's; composition comprising pioglitazone.
BR112014030743A2 (en) neprilysin inhibitors
CR20140554A (en) DIMETIL-BENZOIC ACID COMPOUNDS
GT201400101A (en) PREPARATION PROCEDURE FOR REPLACED 5-FLUORO-1H-PIRAZOLOPIRIDINAS
MX2020003096A (en) Pharmaceutical formulations of a hif hydroxylase inhibitor.
BR112014014939A2 (en) seed treatment composition
CR20140435A (en) NEW DERIVATIVES OF TIENOPIRIMIDINE, PROCESSES FOR ITS PREPARATION AND THERAPEUTIC USES
BR112015002275A2 (en) processes and intermediates for the preparation of integrase inhibitors
GT201400242A (en) "NEW COMPOUNDS OF PIRAZOL"
GT201400288A (en) "PIPERIDINE PHENOXIETIL COMPOUNDS"
MX2016006975A (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases.
DOP2016000120A (en) NEW DGAT2 INHIBITORS
ECSP13012366A (en) PERINDOPRILE L-ARGININE SALT PREPARATION PROCEDURE
BR112014017587A8 (en) Methods and Formulations for the Treatment of Sialic Acid Deficiencies
CO6801728A2 (en) Formulation of adequate lipomoses to treat or prevent tuberculosis
BR112014026326A2 (en) composition for treatment of metabolic disorders
BR112014009760A8 (en) sialic acid analogs
CY1119470T1 (en) LACTIC PHOSPHATIDYLSERIN-BASED COMPOSITIONS

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B350 Update of information on the portal [chapter 15.35 patent gazette]